Customer Success

Enterprises involved in therapeutic antibody R&D are choosing Geneious Biologics to screen and manage their antibody sequence data, transforming data management and significantly speeding up candidate selection.

“The Geneious team has done an excellent job accommodating our specific data, resulting in a streamlined, high-throughput workflow that produces accurate data and operates efficiently without the need to integrate multiple bioinformatics platforms. We look forward to continuously improving the platform and its integration into our workflow to combine sequence analytics with metadata and assay data to accelerate candidate selection.”

Dr. Colby Souders, Chief Technology Officer at Abveris

Abveris is a premium Boston-area contract research organization specializing in antibody discovery. Abveris partners with large and small biopharmaceutical companies to discover novel therapeutic products and critical reagent antibodies using diverse platforms. Additional information about Abveris is available at www.abveris.com.

LifeArc is the charity helping turn promising science into benefits for patients.  They have a 25-year legacy of collaborating with scientists on diagnostics and therapies, enhancing and protecting innovation and advancing promising research. More information: www.lifearc.org.

“The real power of Geneious Biologics is its superb flexibility that enables the development of bespoke workflows for data processing and analysis. Geneious Biologics is a true one-stop destination for any type of antibody sequencing data analysis.”

Dr. Arkadiusz Oleksy, Principal Scientist & Team Leader at LifeArc

The Geneious team has done an excellent job accommodating our specific data, resulting in a streamlined, high-throughput workflow that produces accurate data and operates efficiently without the need to integrate multiple bioinformatics platforms.
Dr. Colby SoudersChief Technology Officer at Abveris